For more than 40 years, the Kronos Quartet—David Harrington (violin), John Sherba (violin), Hank Dutt (viola), and Sunny Yang (cello)—has pursued a singular artistic vision, combining a spirit of ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

We rarely invite the same band back to the Tiny Desk. But the beloved Kronos Quartet, which first played our offices 12 years ago, isn't the same band. Three of the four members are brand new: Cellist ...

Korg has expanded its catalogue of virtual instruments with the release of Collection 6, a newly-updated version of its suite of software recreations of classic Korg synths. Korg launched its Legacy ...

UK-based Ignota Labs has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US company ceased operations earlier this year. Ignota specialises in turning around promising ...

Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...

Get exclusive reporting, live Q&As and ad-free reading. It’s a question Asa Chandler hasn’t stopped asking since he heard his old friend Tony Kronos was missing. The 40-year-old was last seen at his ...

Concentra Biosciences inked a definitive deal to acquire Kronos Bio’s common stock for 57 cents per share. (cagkansayin/GettyImages) With the walls quickly closing ...

Emre Pala is a guide writer from Turkey. He is delving into the gaming world by experimenting with various Pokémon games, wrote Pokémon guides on Turkish forum sites. Later, to popularize Pokémon in ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

The latest round of cuts at the company follows two other staff reductions announced since November of last year. (iStock / Getty Images Plus) On the heels Kronos Bio’s decision to can its last ...